The Ensign Group, Inc.
NASDAQ:ENSGMedical - Care Facilities
-$1.09 today
- Market cap
- $10.68B
- Beta
- 0.68
- P/E (TTM)
- 24.8
- EPS (TTM)
- $6.29
- Dividend yield
- 0.16%
Volume 0.27M
Average 0.56M
ENSG Sales of Investments
Cash received from selling or redeeming investments.
The Ensign Group, Inc.NASDAQ: ENSG
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments dips below year-ago levels
Q2 FY2026 sales of investments of $15.01M fell 57.6% year over year, behind the +51.0% change in trailing-twelve-month sales of investments. Sequentially, it fell 49.5% from the prior quarter. Over 3 fiscal years it compounded at +90.8% a year.
Context
- Sales of investments amounted to 2.0% of revenue in FY2025, up 1.4 pp from a year earlier.
- Sales of investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -57.6% toward the trailing-twelve-month pace of +51.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 99.67M USD
- Year-over-year change
- +277.6%
- 4-year CAGR
- +38.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 99.67M | +277.6% |
| FY2024 | 2024-12-31 | 26.4M | +40.0% |
| FY2023 | 2023-12-31 | 18.85M | +31.3% |
| FY2022 | 2022-12-31 | 14.36M | -47.8% |
| FY2021 | 2021-12-31 | 27.48M | — |
Sales of Investments vs competitors
How ENSG compares with its peers on the latest reported figures
- ENSG's LTM Jun 2026 sales of investments of $91.14M is the 3rd largest of the 11 companies compared; the peer median is $10.54M.
- Its year-over-year change of +51.0% is the 4th highest of 8, against a peer median of -23.8%.
- Sales of investments amounts to 1.7% of revenue for ENSG, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $175M | +525.0% | +72.6% | 0.2% | |
| LTM Mar 2026 | $145M | +59.3% | +3.8% | 0.7% | |
| LTM Jun 2026 | $91.14M | +51.0% | +90.8% | 1.7% | |
| LTM Jun 2026 | $87.6M | -23.8% | — | 1.4% | |
| LTM Sep 2026 | $30.73M | -60.0% | +13.4% | 1.9% | |
| LTM Jun 2026 | $19.91M | -35.8% | — | 0.4% | |
| LTM Sep 2026 | $1.16M | -98.2% | -59.9% | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding ENSG) | $10.54M | -23.8% | +8.6% | 0.1% | |
Competitors are the stored peer set for ENSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 197.73M | 224.65M | 209.85M | 298.46M | 344.26M |
| Depreciation & Amortization | 55.99M | 62.36M | 72.39M | 84.14M | 104.33M |
| Deferred Income Tax | (24.88M) | (6.5M) | (27.48M) | 635K | (16.86M) |
| Stock-Based Compensation | 18.68M | 22.72M | 30.77M | 36.23M | 48.3M |
| Change in Working Capital | 33K | (36.94M) | 37.89M | (75.16M) | 77.92M |
| Accounts Receivables | (30.77M) | (82.43M) | (79.82M) | (84.4M) | (70.43M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 7.12M | 17.87M | 15.92M | 2.84M | (2.92M) |
| Other Working Capital | 23.69M | 27.61M | 101.79M | 6.41M | 151.28M |
| Other Non-Cash Items | 28.14M | 6.23M | 53.25M | 2.89M | 6.31M |
| Operating Cash Flow | 275.68M | 272.51M | 376.67M | 347.19M | 564.27M |
| Capital Expenditures | (69.55M) | (87.55M) | (106.18M) | (158.24M) | (193.56M) |
| Acquisitions (Net) | (7.98M) | (16.4M) | 0 | 0 | 0 |
| Purchases of Investments | (32.26M) | (21.98M) | (30.82M) | (105.15M) | (110.72M) |
| Sales of Investments | 27.48M | 14.36M | 18.85M | 26.4M | 99.67M |
| Other Investing Activities | (91.6M) | (74.62M) | (64.55M) | (153.06M) | (308.57M) |
| Investing Cash Flow | (173.91M) | (186.18M) | (182.7M) | (390.05M) | (513.18M) |
| Debt Repayment | 42.16M | (3.7M) | (3.88M) | (3.95M) | (4.09M) |
| Common Stock Issued | 0 | 6.69M | 0 | 0 | 29.04M |
| Common Stock Repurchased | (11.83M) | (31.58M) | (1.93M) | (1.21M) | (21.43M) |
| Dividends Paid | (11.55M) | (12.17M) | (12.89M) | (13.67M) | (14.41M) |
| Other Financing Activities | (94.92M) | 2.51M | 18.09M | 16.67M | (924K) |
| Financing Cash Flow | (76.14M) | (32.26M) | (612K) | (2.16M) | (11.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.64M | 54.07M | 193.36M | (45.03M) | 39.28M |
| Free Cash Flow | 206.13M | 184.97M | 270.49M | 188.95M | 370.71M |
The Ensign Group, Inc.
NASDAQ:ENSG
Intrinsic Alpha fair value
Locked
Current Price
$182.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.